This announcement is a separate document:
仙琚制药：关于甲磺酸倍他司汀片药品注册申请获得受理的公告
Xianju Pharmaceutical: Notice on acceptance of the application for registration of betahistine mesylate tablets
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated